Cancer Genomics Consortium (CGC) Annual Meeting 2026

Overview

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. Sequence short to ultra-long DNA/RNA fragments, for a streamlined and rapid solution to comprehensively characterise cancer and tumour research samples: from SNVs to epigenetic alterations and large-scale structural aberrations.

We're looking forward to CGC 2026. Visit the Oxford Nanopore booth to speak to our experts about your application.